Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan;86(1):21-7.
doi: 10.1111/j.1349-7006.1995.tb02983.x.

In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors

Affiliations

In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors

Y Katahira et al. Jpn J Cancer Res. 1995 Jan.

Abstract

We investigated an in vitro method to produce cytotoxic T lymphocytes (CTLs) against HTLV-I-infected T-cells using peripheral blood mononuclear cells (PBMC) of adult T-cell leukemia (ATL) patients, asymptomatic HTLV-I carriers (AC) and seronegative healthy donors. The PBMC were restimulated repeatedly for 4 weeks with HLA-matched HTLV-I-infected T-cells which had been pretreated at 56 degrees C for 30 min to inactivate infectious HTLV-I. The culture medium included 10-100 units/ml of recombinant lymphokines (rIL-1, rIL-2, rIL-4, rIL-6 and rIL-7) and 10% fetal calf serum in RPMI-1640 medium. The cytotoxic activity was measured against HLA-matched HTLV-I-infected T-cell lines after CD4+ or CD8+ cells were positively panned from the cultured PBMC. The PBMC of ATL, AC and healthy donors were able to produce either CD4+ or CD8+ CTLs against HTLV-I-related antigens (env, gag, p21x, p27rex and p40tax) as well as the antigen(s) of as-yet unknown specificity expressed on HTLV-I-infected T-cells. All the CTLs recognized the specific antigens in the context of either class I or class II HLA types. These results indicated that ATL patients, AC and healthy donors were immunocompetent to generate CTLs against HTLV-I-infected T-cells and probably against HTLV-I-transformed T-cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. ) Uchiyama , T. , Yodoi , J. , Sagawa , K. , Takatsuki , K. and Uchino , H.Adult T‐cell leukemia: clinical and hematologic features of 16 cases . Blood , 50 , 481 – 491 ( 1977. ). - PubMed
    1. ) Shimoyama , M.and members of The Lymphoma Study Group(1984–87) . Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukemia‐lymphoma . Br. J. Haematol. , 79 , 428 – 437 ( 1991. ). - PubMed
    1. ) Shimoyama , M.and members of The Lymphoma Study Group(1981–83) . Major prognostic factor of adult patients with advanced T‐cell lymphoma/leukemia . J. Clin. Oncol. , 6 , 1088 – 1097 ( 1988. ). - PubMed
    1. ) Kannagi , M. , Sugamura , K. , Sato , H. , Okochi , K. , Uchino , H. and Hinuma , Y.Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus‐bearing cells . J. Immunol. , 130 , 2942 – 2946 ( 1983. ). - PubMed
    1. ) Usuku , K. , Sonoda , S. , Osame , M. , Yashiki , S. , Takahashi , K. , Katsumoto , M. , Sawada , T. , Tsuji , K. , Tara , M. and Igata , A.HLA haplotype‐linked high immune responsiveness against HTLV‐I in HTLV‐I‐associated myelopathy: comparison with adult T‐cell leukemia/lymphoma . Ann. Neurol. , 23 ( Suppl. ), S143 – S150 ( 1988. ). - PubMed

Publication types

LinkOut - more resources